Found: 74
Select item for more details and to access through your institution.
The impact of CD56 expression in smoldering myeloma patients on early progression.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 587, doi. 10.1002/hon.3104
- By:
- Publication type:
- Article
Vacuolated and signet-ring plasma cells in Waldenström macroglobulinemia.
- Published in:
- 2023
- By:
- Publication type:
- Letter
The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4893, doi. 10.3390/ijms24054893
- By:
- Publication type:
- Article
Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15448, doi. 10.3390/ijms232415448
- By:
- Publication type:
- Article
Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1015402
- By:
- Publication type:
- Article
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 704, doi. 10.1002/hon.3031
- By:
- Publication type:
- Article
MicroROM: An efficient and accurate reduced order method to solve many-query problems in micro-motility.
- Published in:
- ESAIM: Mathematical Modelling & Numerical Analysis (ESAIM: M2AN), 2022, v. 56, n. 4, p. 1151, doi. 10.1051/m2an/2022038
- By:
- Publication type:
- Article
Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?
- Published in:
- Transplant International, 2021, v. 34, n. 12, p. 2442, doi. 10.1111/tri.14115
- By:
- Publication type:
- Article
[<sup>18</sup>F](2 S ,4 R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.760732
- By:
- Publication type:
- Article
OAB-004: Carfilzomib-based induction/consolidation with or without autologous transplant and Lenalidomide (R) or Carfilzomib-Lenalidomide (KR) maintenance: efficacy in high-risk patients of the FORTE study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S3, doi. 10.1016/S2152-2650(21)02078-4
- By:
- Publication type:
- Article
P-016: The role [18F]-(2S,4R)-4-Fluoroglutamine as a new positron emission tomography tracer in Myeloma in vivo models.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S47, doi. 10.1016/S2152-2650(21)02150-9
- By:
- Publication type:
- Article
P-139: The impact of CD56 expression in smoldering Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S111, doi. 10.1016/S2152-2650(21)02266-7
- By:
- Publication type:
- Article
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.684561
- By:
- Publication type:
- Article
HDR4CV: High Dynamic Range Dataset with Adversarial Illumination for Testing Computer Vision Methods.
- Published in:
- Journal of Imaging Science & Technology, 2021, v. 65, n. 4, p. 1, doi. 10.2352/J.ImagingSci.Technol.2021.65.4.040404
- By:
- Publication type:
- Article
Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 6, p. 1360, doi. 10.3390/cells10061360
- By:
- Publication type:
- Article
The Role of Proteasome Inhibitors in Multiple Myeloma Bone Disease and Bone Metastasis: Effects on Osteoblasts and Osteocytes.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 10, p. 4642, doi. 10.3390/app11104642
- By:
- Publication type:
- Article
Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?
- Published in:
- Acta Haematologica, 2021, v. 144, n. 3, p. 302, doi. 10.1159/000509768
- By:
- Publication type:
- Article
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score.
- Published in:
- 2021
- By:
- Publication type:
- Letter
A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 389, doi. 10.3390/vaccines9040389
- By:
- Publication type:
- Article
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1235, doi. 10.3390/cancers13061235
- By:
- Publication type:
- Article
Oncolytic Virotherapy and Microenvironment in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2259, doi. 10.3390/ijms22052259
- By:
- Publication type:
- Article
Optimizing the Outcome of Anti-Myeloma Treatment with Daratumumab.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 5, p. 1002, doi. 10.3390/jcm10051002
- By:
- Publication type:
- Article
PD-L1/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-Suppression.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 164, doi. 10.3390/cancers13020164
- By:
- Publication type:
- Article
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.613007
- By:
- Publication type:
- Article
Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus.
- Published in:
- Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 80, doi. 10.33393/grhta.2021.2245
- By:
- Publication type:
- Article
The Circular Life of Human CD38: From Basic Science to Clinics and Back.
- Published in:
- Molecules, 2020, v. 25, n. 20, p. 4844, doi. 10.3390/molecules25204844
- By:
- Publication type:
- Article
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2864, doi. 10.3390/jcm9092864
- By:
- Publication type:
- Article
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 3022, doi. 10.3390/jcm9093022
- By:
- Publication type:
- Article
CD14<sup>+</sup>CD16<sup>+</sup> monocytes are involved in daratumumab‐mediated myeloma cells killing and in anti‐CD47 therapeutic strategy.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 3, p. 430, doi. 10.1111/bjh.16548
- By:
- Publication type:
- Article
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00919-w
- By:
- Publication type:
- Article
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1332, doi. 10.3390/cancers12051332
- By:
- Publication type:
- Article
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 782, doi. 10.3390/cancers12040782
- By:
- Publication type:
- Article
Functional Consequences of Low Activity of Transport System A for Neutral Amino Acids in Human Bone Marrow Mesenchymal Stem Cells.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 5, p. 1899, doi. 10.3390/ijms21051899
- By:
- Publication type:
- Article
CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 12, p. 1632, doi. 10.3390/cells8121632
- By:
- Publication type:
- Article
Glutamine addiction of myeloma cells shapes the metabolic features of the bone microenvironment and impairs osteoblast differentiation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e37, doi. 10.1016/j.clml.2019.09.056
- By:
- Publication type:
- Article
Maintenance Therapy vs Re-treatment at Biochemical Relapse vs Observation in Relapsed/Refractory Multiple Myeloma Patients: Results of a Phase II, Randomized Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e271, doi. 10.1016/j.clml.2019.09.447
- By:
- Publication type:
- Article
Editorial: Immunotherapy in Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 321, doi. 10.3390/cancers11030321
- By:
- Publication type:
- Article
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 261, doi. 10.3390/cancers11020261
- By:
- Publication type:
- Article
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13045-018-0691-4
- By:
- Publication type:
- Article
Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0689-y
- By:
- Publication type:
- Article
Bone marrow Dikkopf‐1 levels are a new independent risk factor for progression in patients with smouldering myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 5, p. 812, doi. 10.1111/bjh.15026
- By:
- Publication type:
- Article
CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02722
- By:
- Publication type:
- Article
Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.02467
- By:
- Publication type:
- Article
Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0666-5
- By:
- Publication type:
- Article
The Proteasome and Myeloma-Associated Bone Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis.
- Published in:
- Case Reports in Hematology, 2018, p. 1, doi. 10.1155/2018/9840405
- By:
- Publication type:
- Article
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
- Published in:
- Hematology Reports, 2018, v. 10, n. 1, p. 23, doi. 10.4081/hr.2018.7457
- By:
- Publication type:
- Article